Escitalopram oxalate and Vomiting aggravated - a phase IV clinical study of FDA data

Summary:

Vomiting aggravated is reported as a side effect among people who take Escitalopram oxalate (escitalopram oxalate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Acetaminophen, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Vomiting aggravated when taking Escitalopram oxalate. It is created by eHealthMe based on reports of 17,508 people who have side effects when taking Escitalopram oxalate from the FDA, and is updated regularly.

What is Escitalopram oxalate?

Escitalopram oxalate has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 17,930 Escitalopram oxalate users. Check the latest studies of Escitalopram oxalate.

What is Vomiting aggravated?

Vomiting aggravated is found to be associated with 1,928 drugs and 731 conditions by eHealthMe. Check the latest studies of Vomiting aggravated.

On Jul, 02, 2026

17,508 people reported to have side effects when taking Escitalopram oxalate.
Among them, 821 people (4.69%) have Vomiting aggravated.

Could Escitalopram oxalate cause Vomiting aggravated?

Among these 821 people:

How long have people been on Escitalopram oxalate when they have Vomiting aggravated? *

Click here to view more results

What is the gender of people who have Vomiting aggravated when taking Escitalopram oxalate? *

Click here to view

What is the age of people who have Vomiting aggravated when taking Escitalopram oxalate? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Escitalopram oxalate and have Vomiting aggravated?

- Check whether Vomiting aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Escitalopram oxalate:

Escitalopram oxalate (17,930 reports)

Vomiting aggravated treatments and more:

Vomiting aggravated (33 reports)

How severe was Vomiting aggravated and when was it recovered:

Vomiting aggravated in Escitalopram oxalate

Expand to all the drugs that have ingredients of escitalopram oxalate:

Vomiting aggravated and drugs with ingredients of escitalopram oxalate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Escitalopram oxalate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vomiting aggravated:

Vomiting aggravated (1,928 drugs)

Browse all the conditions that are associated with Vomiting aggravated:

Vomiting aggravated (731 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate (the active ingredients of Escitalopram oxalate) and Escitalopram oxalate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.